The leading market experts have placed a mean price target of $82.50 on Quest Diagnostics Incorporated (NYSE:DGX) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $1.29 a share for the upcoming quarter and $5.11 for the current fiscal.
The technical analysis of Quest Diagnostics Incorporated plainly substantiates that the 50-day moving average of Quest Diagnostics Incorporated is $84.54, and stock is trading $-0.10 points away or -0.11% from its 50-day moving average of $84.54. Further it is trading $8.15 or +10.68% away its 200-day moving average of $76.29. Quest Diagnostics Incorporated (NYSE:DGX) 52-week high is $86.85 and the 52-week low is $59.66.
This explains if the stock moves $-2.41, it will post a 52-week high. In event of +41.54% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Quest Diagnostics Incorporated , shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Quest Diagnostics Incorporated (NYSE:DGX) ratio came in at 14.73.
The stock last ended the trading session at $84.44 and registered a market cap of $11.74B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Quest Diagnostics Incorporated (NYSE:DGX) PEG ratio is at 2.08.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...